This book covers both molecular and clinical aspects of Fragile X
Syndrome (FXS) and premutation disorders so that new targeted treatments
can be understood by clinicians and parents. It covers all premutation
disorders including FXTAS, FXPOI and FXAND problems. The main focus is
to help clinicians to give the best care possible to patients with FXS
and to understand a multidisciplinary treatment approach. Underserved
populations such as babies and toddlers with FXS and mothers with the
full mutation are highlighted, including the treatments that can be
beneficial to them. This book also discuss fragile X associated
disorders as they impact the family whose proband has FXS. A highlight
of this book is the international perspective on how different cultures
deal with FXS and targeted treatments.